Medical Policy
Policy Num: 07.001.172
Policy Name: Suture Button Suspensionplasty Fixation System for Thumb Carpometacarpal Osteoarthritis
Policy ID: [07.001.172] [Ac / B / M- / P-] [7.01.176]
Last Review: November 14, 2024
Next Review: November 20, 2025
Related Policies:
07.001.129- Synthetic Cartilage Implants for Joint Pain
Population Reference No. | Populations | Interventions | Comparators | Outcomes |
1 | Individuals: · With thumb carpometacarpal (CMC) joint osteoarthritis who have not responded to conservative treatment | Interventions of interest are: · Trapeziectomy using suture button suspensionplasty | Comparators of interest are: · Surgery without suture button suspensionplasty | Relevant outcomes include: · Symptoms · Functional outcomes · Adverse events |
In the thumb, the most common site for arthritis to develop is in the joint at the base of the thumb, also known as the carpometacarpal (CMC) joint. Pain and functional limitations associated with symptomatic thumb CMC joint osteoarthritis, especially when pinching or gripping objects, can significantly interfere with quality of life. Surgery is indicated when conservative measures fail to provide sufficient relief and functional improvement. There is currently no consensus on the optimal surgical approach, but the most frequently used procedure is trapeziectomy with ligament reconstruction and tendon interposition (LRTI). Trapeziectomy using suture button suspensionplasty (SBS) is proposed as a less invasive alternative to trapeziectomy with LRTI.
For individuals with thumb carpometacarpal (CMC) joint osteoarthritis who receive trapeziectomy with suture button suspensionplasty (SBS), the evidence includes a systematic review, 1 randomized controlled trial (RCT), 1 prospective, comparative observational study, and multiple nonrandomized, retrospective studies. Relevant outcomes are symptoms, functional outcomes, and adverse events. A single-center RCT compared trapeziectomy with SBS to trapeziectomy with ligament reconstruction and tendon interposition (LRTI) in 76 individuals. The RCT had multiple methodologic limitations, including lack of blinding, inappropriate handling of missing data, and no pre-specification of outcome measures. Pain and functional outcomes did not differ between intervention groups after 40 months of follow-up, although operative and recovery time was shorter in the suspensionplasty group. A prospective cohort study of 112 consecutive individuals who underwent suture button suspensionplasty or LRTI found similar improvements in pain scores and function with both procedures, but was limited by a lack of blinding and randomization. Retrospective studies reported improvements in pain and function but are limited by their design. Additionally, multiple surgical techniques to treat thumb CMC joint osteoarthritis have been developed but there is currently no consensus on the optimal approach, limiting conclusions that can be drawn from comparative studies. The evidence is insufficient to determine that the technology results in an improvement in the net health outcome.
Not applicable.
The objective of this evidence review is to determine if suture button suspensionplasty as an adjunct to trapeziectomy improves the net health outcome in individuals with thumb carpometacarpal joint osteoarthritis.
Suture button suspensionplasty for thumb carpometacarpal joint osteoarthritis is considered investigational.
See the Codes table for details.
State or federal mandates (eg, Federal Employee Program) may dictate that certain U.S. Food and Drug Administration approved devices, drugs, or biologics may not be considered investigational, and thus these devices may be assessed only by their medical necessity.
Benefits are determined by the group contract, member benefit booklet, and/or individual subscriber certificate in effect at the time services were rendered. Benefit products or negotiated coverages may have all or some of the services discussed in this medical policy excluded from their coverage.
In the thumb, the most common site for arthritis to develop is in the joint at the base of the thumb, also known as the carpometacarpal (CMC) joint. The incidence of CMC joint osteoarthritis is estimated to be 5% to 33% among adults in their 50s and 60s, and rises with age. It is more common in postmenopausal women. Pain and functional limitations, especially when pinching or gripping objects, can significantly interfere with quality of life.1,
First-line treatment of CMC joint osteoarthritis includes non-surgical measures such as activity modifications, rest, hand orthosis, anti-inflammatory medications, physical therapy, and corticosteroid injections.2, Surgery is indicated when conservative treatment fails to provide sufficient relief and functional improvement. Although thumb CMC joint osteoarthritis is often staged using radiological classification systems (e.g., the Eaton-Littler classification), the severity of symptoms does not necessarily correspond to radiographic findings; therefore a decision to proceed to surgery is based on symptoms and degree of disability.3,
Multiple surgical techniques to treat thumb CMC osteoarthritis have been developed but there is currently no consensus on the optimal approach.3,4,5, The most common surgical technique is removal of the trapezium bone at the base of the thumb (trapeziectomy). Trapeziectomy can be performed alone but is most commonly performed in conjunction with reconstruction of the ligament that holds the bones between the thumb and index finger together, and filling the space left behind by the removed trapezium with tendon harvested from the forearm to support the thumb. This procedure is known as trapeziectomy with ligament reconstruction and tendon interposition (LRTI). Either the flexor carpi radialis (FCR) tendon or abductor pollicis longus (APL) tendon is used in this procedure.
Trapeziectomy using suture button suspensionplasty is proposed as a less invasive alternative to trapeziectomy with LRTI. Instead of using tendon to support the thumb, the procedure suspends the first metacarpal to the second using a strong suture material (fiberwire) passed through both bones. A button on each of the metacarpals is attached to either end of the suture to secure the bones in the correct position.
In 2014, the CMC Mini TightRope System (Arthrex, Inc) was FDA cleared through the 510K process.6, Clearance was based on a determination that the device is substantially equivalent to the predicate device Arthrex Implant System (Mini TightRope). The CMC MiniTightRope system is indicated for CMC joint arthroplasty as an adjunct in the suspension of the thumb metacarpal by providing stabilization at the base of the first and second metacarpal when the trapezium has been excised due to osteoarthritis.
Product code: HTN
This evidence review was created in September 2023 with a search of the PubMed database. The most recent literature search was performed through September 25, 2024.
Evidence reviews assess the clinical evidence to determine whether the use of a technology improves the net health outcome. Broadly defined, health outcomes are length of life, quality of life, and ability to function including benefits and harms. Every clinical condition has specific outcomes that are important to patients and to managing the course of that condition. Validated outcome measures are necessary to ascertain whether a condition improves or worsens; and whether the magnitude of that change is clinically significant. The net health outcome is a balance of benefits and harms.
To assess whether the evidence is sufficient to draw conclusions about the net health outcome of a technology, 2 domains are examined: the relevance and the quality and credibility. To be relevant, studies must represent one or more intended clinical use of the technology in the intended population and compare an effective and appropriate alternative at a comparable intensity. For some conditions, the alternative will be supportive care or surveillance. The quality and credibility of the evidence depend on study design and conduct, minimizing bias and confounding that can generate incorrect findings. The randomized controlled trial is preferred to assess efficacy; however, in some circumstances, nonrandomized studies may be adequate. Randomized controlled trials are rarely large enough or long enough to capture less common adverse events and long-term effects. Other types of studies can be used for these purposes and to assess generalizability to broader clinical populations and settings of clinical practice.
Promotion of greater diversity and inclusion in clinical research of historically marginalized groups (e.g., People of Color [African-American, Asian, Black, Latino and Native American]; LGBTQIA (Lesbian, Gay, Bisexual, Transgender, Queer, Intersex, Asexual); Women; and People with Disabilities [Physical and Invisible]) allows policy populations to be more reflective of and findings more applicable to our diverse members. While we also strive to use inclusive language related to these groups in our policies, use of gender-specific nouns (e.g., women, men, sisters, etc.) will continue when reflective of language used in publications describing study populations.
Population Reference No. 1
The following PICO was used to select literature to inform this review.
The relevant population of interest is individuals with thumb carpometacarpal (CMC) joint osteoarthritis who have not responded to conservative treatment.
The therapy being considered is suture button suspensionplasty with the CMC Mini TightRope System. Suture button suspensionplasty is intended to provide stabilization at the base of the first and second metacarpal following trapeziectomy for CMC joint osteoarthritis. The system suspends the first metacarpal to the second using suture material (fiberwire) passed through both bones. A button on each of the metacarpals is attached to either end of the suture to secure the bones in the correct position.
Multiple surgical techniques to treat thumb CMC osteoarthiriis have been developed but there is currently no consensus on the optimal approach.3,5, The most common surgical technique is removal of the trapezium bone at the base of the thumb (trapeziectomy). Trapeziectomy can be performed alone but is most commonly performed in conjunction with reconstruction of the ligament that holds the bones between the thumb and index finger together and filling the space left behind by the removed trapezium with tendon harvested from the forearm to support the thumb. This procedure is known as trapeziectomy with ligament reconstruction and tendon interposition (LRTI).
The general outcomes of interest are symptoms, functional outcomes, and treatment-related morbidity.
The Disabilities of the Arm, Shoulder and Hand (DASH) and QuickDASH Questionnaires and the Visual Analog Scale for pain are patient-reported outcome measures commonly used to assess surgical treatment of thumb CRC osteoarthritis (Table 1).
There are no guidelines specific to the duration of follow-up to assess outcomes of thumb CMC joint surgery. Long-term follow-up over years would be of interest to assess pain, function, and procedure-related adverse events. The only published RCT of SBS specified at least 2 years of follow-up for inclusion in the analysis.7, Both immediate operative complications and longer-term adverse events would be of interest.
One proposed advantage of SBS over LRTI is a reduction in the occurrence of subsidence (the collapse or settling of bone located immediately next to an implantable device). However, there is no consensus on how to measure subsidence and its correlation to symptoms is not clear.
Table 1. Outcome Measures
Outcome | Measure | Scale Description and Administration | Minimal Clinically Important Difference |
Pain | Visual analog scale | 0-10, Lower score means reduced pain | 1.4, 1.6-1.9 points8, |
Pain and function | Disabilities of the Arm, Shoulder and Hand (DASH) | A 30 Item self-reported questionnaire that measures an individuals' ability to complete tasks, absorb forces and severity of symptoms. Lower scores indicate better functional outcomes. | 11-15 points9, |
Pain and function | Disabilities of the Arm, Shoulder and Hand Questionnaire, QuickDASH | Abbreviated version of DASH (11 items) | 16-20 points9, |
Revision Surgery rates | Frequency, percent | NA | NA |
Surgical Complications | Frequency, percent | NA | NA |
Methodologically credible studies were selected using the following principles:
To assess efficacy outcomes, comparative controlled prospective trials were sought, with a preference for RCTs;
In the absence of such trials, comparative observational studies were sought, with a preference for prospective studies.
To assess long-term outcomes and adverse events, single-arm studies that capture longer periods of follow-up and/or larger populations were sought.
Studies with duplicative or overlapping populations were excluded.
Wininger et al (2022) published a systematic review of LRTI compared to SBS for carpometacarpal joint osteoarthritis, with searches conducted through November 2020.1, Study eligibility criteria included reporting of postoperative DASH or QuickDASH scores. The quality of the overall body of evidence for each intervention was rated for quality, quantity, and consistency using Strength of Recommendation Taxonomy (SORT) criteria.
The analysis included 31 studies (LRTI: 25 studies [1289 thumbs]; SBS: 6 studies [113 thumbs]). At the time the review was conducted, no studies directly comparing SBS to LRTI had been published. The body of evidence for SBS was rated SORT C (based on case series) and for LRTI was rated SORT B (based on inconsistent or limited-quality patient-oriented evidence). In studies that reported both pre-operative and post-operative data, DASH or QuickDash scores improved following either LRTI and SBS. Grip strength and key pinch were similarly improved but inconsistently reported across studies. Overall, complications occurred in 12.3% of 740 individuals who underwent LRTI and 13.3% of 113 who underwent SBS. There were 6 re-operations in the LRTI studies (of which 4 came from RCTs) and 2 re-operations in the SBS studies. Complete reporting of complications varied greatly between studies and follow-up times were generally short, precluding any conclusions on long-term complications associated with each procedure.
The authors noted multiple limitations of the body of the evidence, including increased risk of bias especially for SBS studies, short follow-up times, and lack of reporting of the time period of postoperative outcome measurements. They concluded that, although both LRTI and SBS seemed to provide improved short-term patient-reported functional improvement and objective strength, larger prospectively designed studies of high-quality evidence are needed to determine whether a difference exists between the 2 techniques.
Morais et al (2022) reported on an RCT, conducted at a single center in Portugal that evaluated SBS for thumb CRC joint osteoarthritis (Table 2).7, The trial compared trapeziectomy with SBS to trapeziectomy with LRTI in 76 individuals. Mean followup was 37.3 months (standard deviation [SD], 12.6) months in the SBS group and 40.5 (SD 14.8) months in the SBS group. Pain and function as assessed by visual analogue scale (VAS) and QuickDash scores at followup improved from baseline in both intervention groups but did not differ between groups (Table 3). The incidence of postoperative complications was also similar in each group. One individual in the SBS and 2 in the LRTI group required reoperation. Of note, 2 individuals in the SBS group and 1 in the LRTI group developed a complex regional pain syndrome requiring physical therapy.
The trial had several important limitations (Tables 4 and 5). Lack of blinding combined with subjective outcome measures poses a serious risk of bias. Outcomes were not prespecified and the trial was not registered. Although the methods section mentions that a power calculation was conducted, no details are given and there is no reporting of pre-specified thresholds for minimally clinically important differences. Generalizability is limited because the trial was conducted at a single center, with all surgeries performed by the same individual. Additionally, 20% of individuals who received surgery were excluded from the analysis. Individuals who were lost to followup (n=5), those who underwent revision surgery (n=7), and those who received associated procedures (n=7) were all classified as ineligible and were not included in the analysis. There was no analysis to account for missing data.
Study; Trial | Countries | Sites | Dates | Participants | Interventions | |
Trapeziectomy with SBS | Trapezeictomy with LRTI | |||||
Morais et al (2022)7, | Portugal | 1 | 2015-2019 | Individuals with thumb carpometacarpal osteoarthritis 9.2% stage II; 64.5% stage III; 26.3% stage IV 88.2% female Race not reported | 39 | 37 |
LRTI: ligament reconstruction and tendon interposition; SBS: suture button suspensionplasty.
Study | Percent of Patients Reporting Pain Relief (SD) | Patient-Reported VAS score at discharge (SD) | Quick DASH score at discharge (SD) | Complications |
Morais et al (2022)7, | ||||
76 | 76 | 76 | 76 | |
SBS | 94.6% | 1.5 (1.4) | 31.6 (20.3) | Postoperative complications (all): 4/37 (11%) Reoperation rate: 1/37 (2.7%) |
LRTI | 92.3% | 1.3 (1.2) | 30.1 (17.8) | Postoperative complications (all): 3/39 (8%) Reoperation rate: 2/39 (5.1%) |
P-value | .6877 | .9658 | .7336 | Postoperative complications (all):.3585 |
LRTI: ligament reconstruction and tendon interposition; SBS: suture button suspensionplasty; SD: standard deviation; VAS: visual analog scale.
Study | Populationa | Interventionb | Comparatorc | Outcomesd | Duration of Follow-upe |
Morais et al (2022)7, | 3. 9.2% of participants had stage 2 osteoarthritis 4. Participants were treated at a single center in Portugal; subpopulations not reported | 5. Clinically significant differences not specified |
The study limitations stated in this table are those notable in the current review; this is not a comprehensive gaps assessment. a Population key: 1. Intended use population unclear; 2. Study population is unclear; 3. Study population not representative of intended use; 4, Enrolled populations do not reflect relevant diversity; 5. Other.b Intervention key: 1. Not clearly defined; 2. Version used unclear; 3. Delivery not similar intensity as comparator; 4. Not the intervention of interest (e.g., proposed as an adjunct but not tested as such); 5: Other.c Comparator key: 1. Not clearly defined; 2. Not standard or optimal; 3. Delivery not similar intensity as intervention; 4. Not delivered effectively; 5. Other.d Outcomes key: 1. Key health outcomes not addressed; 2. Physiologic measures, not validated surrogates; 3. Incomplete reporting of harms; 4. Not establish and validated measurements; 5. Clinically significant difference not prespecified; 6. Clinically significant difference not supported; 7. Other.e Follow-Up key: 1. Not sufficient duration for benefit; 2. Not sufficient duration for harms; 3. Other.
Study | Allocationa | Blindingb | Selective Reportingc | Data Completenessd | Powere | Statisticalf |
Morais et al (2022)7, | 3. Not described | 1. Participants and surgeon not blinded; 1 surgeon performed all procedures 2. outcome assessor described as independent, but not clear if blinded | 1. Trial not registered; outcomes not pre-specified; clinically important differences on outcomes not pre-specified. |
| 1. Methods section states that a power analysis was performed but no details | 3. Methods section notes that confidence intervals were calculated, but none reported in results 4. No calculation of comparative treatment effects |
The study limitations stated in this table are those notable in the current review; this is not a comprehensive gaps assessment.a Allocation key: 1. Participants not randomly allocated; 2. Allocation not concealed; 3. Allocation concealment unclear; 4. Inadequate control for selection bias; 5. Other.b Blinding key: 1. Participants or study staff not blinded; 2. Outcome assessors not blinded; 3. Outcome assessed by treating physician; 4. Other.c Selective Reporting key: 1. Not registered; 2. Evidence of selective reporting; 3. Evidence of selective publication; 4. Other.d Data Completeness key: 1. High loss to follow-up or missing data; 2. Inadequate handling of missing data; 3. High number of crossovers; 4. Inadequate handling of crossovers; 5. Inappropriate exclusions; 6. Not intent to treat analysis (per protocol for noninferiority trials); 7. Other.e Power key: 1. Power calculations not reported; 2. Power not calculated for primary outcome; 3. Power not based on clinically important difference; 4. Other.f Statistical key: 1. Analysis is not appropriate for outcome type: (a) continuous; (b) binary; (c) time to event; 2. Analysis is not appropriate for multiple observations per patient; 3. Confidence intervals and/or p values not reported; 4. Comparative treatment effects not calculated; 5. Other.
Prospective Cohort Study
Shonuga et al (2023) conducted a prospective cohort study of 112 consecutive individuals who underwent SBS or LRTI (Table 6).10, Individuals who underwent SBS had significantly lower QuickDASH scores at 1 year postoperatively compared with those who underwent LRTI (Table 7). The 14-point difference between groups exceeded the minimum clinically important difference (MCID) prespecified by the study investigators; however there was no rationale provided for this threshold, and other researchers have recommended a MCID of 16 to 20 points on the QuickDash.9, No fractures or reoperations occurred in either group. No details on other complications or adverse events are reported. Study limitations are shown in Tables 8 and 9. Lack of blinding and randomization pose a serious risk of bias. Additional limitations are the relatively short-term followup period and variation in the surgical procedures used in the LRTI group.
Study | Study Type | Country | Dates | Participants | Trapeziectomy with SBS | Trapeziectomy with LRTI | Follow-Up |
Shonuga et al (2023)10, | Prospective Cohort | US | 2015-2017 | 112 consecutive individuals with Eaton stage 3-4 thumb CMC arthritis who underwent open trapeziectomy and suspensionplastyt. 71.4% female Mean age 63 years (range 44-80) Race not reported | n = 59 | n = 53 | 1 year |
LRTI: ligament reconstruction and tendon interposition; SBS: suture button suspensionplasty
Study | QuickDASH Questionnaire Score at 12 months | VAS for pain Score at 12 months | Lateral Pinch Strength | Post-Operative Complications |
Shonuga et al (2023)10, | ||||
SBS | 7.5 | 0.3 | 5.7 kg | No fractures or reoperations in either group; no additional details |
LRTI | 21.5 | 0.6 | 5.2 kg | |
P-value | <.05 | <.05 | <.99 |
LRTI: ligament reconstruction and tendon interposition; SBS: suture button suspensionplasty; VAS: visual analog scale.
Study | Populationa | Interventionb | Comparatorc | Outcomesd | Duration of Follow-upe |
Shonuga et al (2023)10, | 5. LRTI procedure used FCR or APL tendon, may be differences in outcomes based on variation in procedures | 3. Limited detail on adverse events; unclear if outcomes prespecified | 1.2. 1-year followup may be insufficient to assess outcomes |
APL: abductor pollicis longus; FCR: flexor carpi radialis; LRTI: ligament reconstruction and tendon interposition.The study limitations stated in this table are those notable in the current review; this is not a comprehensive gaps assessment. a Population key: 1. Intended use population unclear; 2. Study population is unclear; 3. Study population not representative of intended use; 4, Enrolled populations do not reflect relevant diversity; 5. Other.b Intervention key: 1. Not clearly defined; 2. Version used unclear; 3. Delivery not similar intensity as comparator; 4. Not the intervention of interest (e.g., proposed as an adjunct but not tested as such); 5: Other.c Comparator key: 1. Not clearly defined; 2. Not standard or optimal; 3. Delivery not similar intensity as intervention; 4. Not delivered effectively; 5. Other.d Outcomes key: 1. Key health outcomes not addressed; 2. Physiologic measures, not validated surrogates; 3. Incomplete reporting of harms; 4. Not establish and validated measurements; 5. Clinically significant difference not prespecified; 6. Clinically significant difference not supported; 7. Other.e Follow-Up key: 1. Not sufficient duration for benefit; 2. Not sufficient duration for harms; 3. Other.
Study | Allocationa | Blindingb | Selective Reportingc | Data Completenessd | Powere | Statisticalf |
Shonuga et al (2023)10, | 1. not randomized | 1. not blinded |
The study limitations stated in this table are those notable in the current review; this is not a comprehensive gaps assessment.a Allocation key: 1. Participants not randomly allocated; 2. Allocation not concealed; 3. Allocation concealment unclear; 4. Inadequate control for selection bias; 5. Other.b Blinding key: 1. Participants or study staff not blinded; 2. Outcome assessors not blinded; 3. Outcome assessed by treating physician; 4. Other.c Selective Reporting key: 1. Not registered; 2. Evidence of selective reporting; 3. Evidence of selective publication; 4. Other.d Data Completeness key: 1. High loss to follow-up or missing data; 2. Inadequate handling of missing data; 3. High number of crossovers; 4. Inadequate handling of crossovers; 5. Inappropriate exclusions; 6. Not intent to treat analysis (per protocol for noninferiority trials); 7. Other.e Power key: 1. Power calculations not reported; 2. Power not calculated for primary outcome; 3. Power not based on clinically important difference; 4. Other.f Statistical key: 1. Analysis is not appropriate for outcome type: (a) continuous; (b) binary; (c) time to event; 2. Analysis is not appropriate for multiple observations per patient; 3. Confidence intervals and/or p values not reported; 4. Comparative treatment effects not calculated; 5. Other.
Retrospective Studies
Multiple retrospective, non-randomized studies have been published.12,13,14,15,9,16,17,18,19,20,These studies are limited by their lack of a comparator, lack of blinded outcome assessment, outcome assessment based on medical record data, and insufficient follow-up duration to assess longer-term outcomes. Because of their methodological limitations they are not discussed further, but are cited for reference only.
In 2024, Lachnish et al published a chart review of 17 out of 50 eligible patients treated with trapeziectomy plus SBS and assessed long-term functional outcomes at 10 years.21, Improvements were seen in QuickDASH scores, grip strength, and pinch strength compared to historical 3 month assessments, with radial and palmar range of motion maintained within 98% and 94%, respectively. These outcomes were observed despite radiographic evidence of subsidence, with the average height of the trapezial space reduced to 69% of the previous measurement in 9/17 patients with available imaging.
The evidence includes a systematic review, 1 RCT, 1 prospective, comparative observational study, and multiple nonrandomized, retrospective studies. Relevant outcomes are symptoms, functional outcomes, and adverse events. A single-center RCT compared trapeziectomy with SBS to trapeziectomy with LRTI in 76 individuals. The RCT had multiple methodologic limitations, including lack of blinding, inappropriate handling of missing data, and no pre-specification of outcome measures. Pain and functional outcomes did not differ between intervention groups after 40 months of follow-up, although operative and recovery time was shorter in the suspensionplasty group. A prospective cohort study of 112 consecutive individuals who underwent suture button suspensionplasty or LRTI found similar improvements in pain scores and function with both procedures, but was limited by a lack of blinding and randomization. Retrospective studies reported improvements in pain and function but have been published but are limited by their design. Additionally, multiple surgical techniques to treat thumb CMC joint osteoarthritis have been developed but there is currently no consensus on the optimal approach, limiting conclusions that can be drawn from comparative studies.
For individuals with thumb carpometacarpal (CMC) joint osteoarthritis who receive trapeziectomy with suture button suspensionplasty (SBS), the evidence includes a systematic review, 1 randomized controlled trial (RCT), 1 prospective, comparative observational study, and multiple nonrandomized, retrospective studies. Relevant outcomes are symptoms, functional outcomes, and adverse events. A single-center RCT compared trapeziectomy with SBS to trapeziectomy with ligament reconstruction and tendon interposition (LRTI) in 76 individuals. The RCT had multiple methodologic limitations, including lack of blinding, inappropriate handling of missing data, and no pre-specification of outcome measures. Pain and functional outcomes did not differ between intervention groups after 40 months of follow-up, although operative and recovery time was shorter in the suspensionplasty group. A prospective cohort study of 112 consecutive individuals who underwent suture button suspensionplasty or LRTI found similar improvements in pain scores and function with both procedures, but was limited by a lack of blinding and randomization. Retrospective studies reported improvements in pain and function but are limited by their design. Additionally, multiple surgical techniques to treat thumb CMC joint osteoarthritis have been developed but there is currently no consensus on the optimal approach, limiting conclusions that can be drawn from comparative studies. The evidence is insufficient to determine that the technology results in an improvement in the net health outcome.
Population Reference No. 1 Policy Statement | [ ] MedicallyNecessary | [X] Investigational |
The purpose of the following information is to provide reference material. Inclusion does not imply endorsement or alignment with the evidence review conclusions.
Guidelines or position statements will be considered for inclusion in 'Supplemental Information' if they were issued by, or jointly by, a US professional society, an international society with US representation, or National Institute for Health and Care Excellence (NICE). Priority will be given to guidelines that are informed by a systematic review, include strength of evidence ratings, and include a description of management of conflict of interest.
In 2019, the American College of Rheumatology/Arthritis Foundation published a guideline on the management of osteoarthritis of the hand, hip, and knee.2, The guideline included recommendations for non-surgical treatment of thumb carpometacarpal (CMC) joint osteoarthritis, but surgical approaches were not addressed.
Not applicable.
There is no national coverage determination. In the absence of a national coverage determination, coverage decisions are left to the discretion of local Medicare carriers.
Some currently unpublished trials that might influence this review are listed in Table 10.
NCT No. | Trial Name | Planned Enrollment | Completion Date |
Ongoing | |||
NCT05111405 | A Randomized Prospective Multicenter Study Comparing Suture Button Suspensionplasty (SBS) With Ligament Reconstruction and Tendon Interposition (LRTI) | 138 | May 2025 |
NCT04458584 | Restoration of Thumb Strength and Function in Basal Joint Arthritis: A Comparative Effectiveness Trial (RESTART) | 165 | July 2026 |
NCT: national clinical trial.
Codes | Number | Description |
---|---|---|
CPT | 26989 | Unlisted procedure, hands or fingers (no specific code for this procedure) |
HCPCS | N/A | |
ICD10 CM | M18.9 | Osteoarthritis of first carpometacarpal joint, unspecified |
ICD10 PCS | N/A | |
Type of Service | Surgery | |
Place of Service | Outpatient/Professional |
N/A
Date | Action | Description |
---|---|---|
11/14/2024 | Annual Review | Policy updated with literature review through September 25, 2024; references added. Policy statements unchanged. |
11/15/2023 | New policy | Policy created with literature review through September 21, 2023. Suture button suspensionplasty for thumb carpometacarpal joint osteoarthritis is considered investigational. |